Swapnil Bhargava
Directeur Technique/Scientifique/R&D chez CG ONCOLOGY, INC.
Postes actifs de Swapnil Bhargava
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CG ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/09/2023 | - |
Historique de carrière de Swapnil Bhargava
Anciens postes connus de Swapnil Bhargava
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - | - |
Formation de Swapnil Bhargava
| University of Maryland | Doctorate Degree |
| Indian Institute of Technology Delhi | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 2 |
| Inde | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- Swapnil Bhargava
- Expérience
